MAM
HLL launches ‘Taj Mahal Sabse Khaas Contest’
MUMBAI: Over the years Taj Mahal Tea has managed to catch one’s attention with the catchphrase Wah Taj! Its campaign involving tabla player Zakir Hussain was a resounding success. Now Taj Mahal has announced the Taj Mahal Sabse Khaas Contest.
An official release informs that the Sabse Khaas Contest rewards consumers of Taj Mahal in a variety of ways – redemption coupons, tea sets and grand prizes to winners in every city. The consumer after buying a packet of Taj Mahal Tea needs to answer the question what makes Taj sabse khaas? and drop off the answer sheet at select retail outlets. Winners will be rewarded at every retail outlet, which will give away one tea set. And a grand prize winner in every city walks away with diamond jewellery worth Rs 80,000..
Besides these prizes, every purchase entitles the consumer to gift coupons that can be redeemed for discounts on a variety of products. The key draw of the contest is its innovative structure. With prizes being given out at the retail level and mega prizes at the city level, the chances for consumers to win are higher.
Hindustan Lever Ltd. Vineet Taneja general manager marketing – beverages said:“What Taj Mahal Tea has consistently offered to connoisseurs is a quality tea drinking experience. It has firmly entrenched itself as the most special tea in the minds of millions of consumers. With this innovative contest, Taj Mahal Tea aims to reward consumers across the nation.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
